Trelegy Ellipta (Fluticasone furoate/umeclidinium/vilanterol)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Trelegy Ellipta (Fluticasone furoate/umeclidinium/vilanterol), covering 2026-02-02 to 2026-02-02. Get the full timeline:
Most recent: Clinical Trial Update: Comparative Effects of Triple Inhaled Therapy With Budesonide/Glycopyrronium/Formoterol Versus Fluticasone Furoate/Umeclidinium/Vilanterol on Small Airway Disease in COPD Patients: A Randomized Crossover Study [Phase 4]